Genetic Mutation Analysis for Hemophilia B (Factor IX Deficiency) - Blood Test

What This Test Measures

The test analyzes DNA from your blood sample to detect specific mutations in the F9 gene, which produces Factor IX. These mutations can result in reduced or absent clotting factor activity, leading to hemophilia B. The method used is typically a genetic sequencing test, such as next-generation sequencing or targeted mutation analysis, to identify these changes precisely.

Why It’s Done

This test may be recommended if you or a family member has a history of hemophilia B, unexplained bleeding, or if you’re considering pregnancy and genetic counseling. It can also be used to screen newborns or assess carriers in inherited bleeding disorders.

Sample Collection and Preparation

A small blood sample is drawn from a vein, usually in your arm. The blood is processed to extract DNA for genetic analysis. No special preparation is needed, but fasting may be advised depending on the clinical context.

Test Results and Interpretation

Results will identify whether you carry the F9 gene mutations associated with hemophilia B. Positive findings indicate a genetic predisposition, while negative results mean no detectable mutations in this test. Interpretation requires clinical correlation with symptoms and family history.